Systematic review South Dakota medicine · 2026 Clostridium innocuum Bacteremia: Case Report and Systematic Review. de Matos-Konrad C, Chima N, Huntington MK [Clostridium] innocuum PubMed ↗
Review Toxins · 2025 The Ambivalent Nature of Bacteroides fragilis and the Interaction with Clostridioides difficile: Benefits and Disadvantages for the Human Host. Spigaglia P Bacteroides fragilis PubMed ↗
Review Anaerobe · 2023 Bacteremia due to Clostridium innocuum: Analysis of four cases and literature review. Cobo F, Pérez-Carrasco V, Tarriño-León M, et al. [Clostridium] innocuum PubMed ↗
Observational Clinical infectious diseases · 2021 Microbiota-associated Risk Factors for Clostridioides difficile Acquisition in Hospitalized Patients: A Prospective, Multicentric Study. Solbach P, Chhatwal P, Woltemate S, et al. Odoribacter splanchnicusRuminococcus bromii PubMed ↗
Microbial pathogenesis · 2026 Vancomycin-resistant gut commensal Clostridium innocuum emerges as a pathobiont through synergy with toxigenic Clostridioides difficile. Kuo CJ, Hsu TS, Hsu CM, et al. [Clostridium] innocuum PubMed ↗
Journal of controlled release · 2026 A multifunctional probiotic co-delivery platform for the treatment of Clostridium difficile infection. Yang H, Kuang Y, Wang L, et al. Bifidobacterium adolescentis PubMed ↗
mSphere · 2025 Microbiome signatures of Clostridioides difficile toxin production and toxin gene presence: a shotgun metagenomic approach. Kwon J, Correa MA, Kong Y, et al. Akkermansia muciniphilaBifidobacterium adolescentisEnterococcus faecalisFlavonifractor plautii PubMed ↗
Microbial pathogenesis · 2025 Novel Enterococcus faecium P2 as a probiotic for mitigating Clostridioides difficile infection. Cui Y, Jia Q, Yan H, et al. Enterococcus faecium PubMed ↗
Microbes and infection · 2025 Lactococcus lactis and Bifidobacterium longum attenuate Clostridioides difficile- or Clostridium symbiosum-induced colitis and depression/anxiety-like behavior in male mice. Joo MK, Ma X, Shin JW, et al. [Clostridium] symbiosumBifidobacterium longumLactococcus lactis PubMed ↗
Cell host & microbe · 2025 Veillonella intestinal colonization promotes C. difficile infection in Crohn's disease. Yang Z, Wang J, Chen Y, et al. Veillonella parvula PubMed ↗
The Journal of infectious diseases · 2025 Rational Design of Live Biotherapeutic Products for the Prevention of Clostridioides difficile Infection. Ke S, Villafuerte Gálvez JA, Sun Z, et al. Dorea formicigeneransFaecalibacterium prausnitzii PubMed ↗
Polish journal of microbiology · 2025 Roles of Gut Microbiota and Associated Metabolites in Clostridioides difficile Infection. Gao Y, Ma J, Wang K, et al. Haemophilus parainfluenzae PubMed ↗
Microbiological research · 2025 Receptor-targeted Lactococcus lactis mitigate Clostridioides difficile infection. Zhang Y, Sun W, Wu H, et al. Lactococcus lactis PubMed ↗
Medical microbiology and immunology · 2025 Impact of vancomycin and Clostridioides difficile on the secretome and pathogenicity of Clostridium innocuum. Chen YM, Chien KY, Shieh HR, et al. [Clostridium] innocuum PubMed ↗
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi · 2025 Fecal microbiota transplantation for vancomycin-resistant Clostridium innocuum infection in inflammatory bowel disease: A pilot study evaluating safety and clinical and microbiota outcome. Le PH, Yeh YM, Chen YC, et al. [Clostridium] innocuum PubMed ↗
Gut microbes · 2025 Synergistic and off-target effects of bacteriocins in a simplified human intestinal microbiome: implications for Clostridioides difficile infection control. Ríos Colombo NS, Paul Ross R, Hill C Lactococcus lactis PubMed ↗
Cell host & microbe · 2024 Phocaeicola vulgatus shapes the long-term growth dynamics and evolutionary adaptations of Clostridioides difficile. Sulaiman JE, Thompson J, Cheung PLK, et al. Phocaeicola vulgatus PubMed ↗
Microbial pathogenesis · 2024 Bifidobacteria antagonize the life cycle of Clostridioides difficile. Soldavini Pelichotti PC, Martinefski MR, Boscolo O, et al. Bifidobacterium adolescentisBifidobacterium bifidum PubMed ↗
Digestive and liver disease · 2024 Long-term stability and efficacy of frozen fecal microbiota transplant (FMT) product at 24 months. Facchin S, Cardin R, Patuzzi I, et al. Bifidobacterium adolescentis PubMed ↗
Nature communications · 2024 Elucidating human gut microbiota interactions that robustly inhibit diverse Clostridioides difficile strains across different nutrient landscapes. Sulaiman JE, Thompson J, Qian Y, et al. [Clostridium] scindens PubMed ↗